Skip to main content
PMC home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1983 Jul;340:403–414. doi: 10.1113/jphysiol.1983.sp014769

Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells.

R Casteels, I S Login
PMCID: PMC1199216  PMID: 6310099

Abstract

The effects of reserpine on excitation-contraction coupling and 45Ca exchange of smooth muscle cells of the rabbit ear artery and the guinea-pig taenia coli have been studied. Reserpine inhibited the spontaneous mechanical activity of the taenia coli and the force development induced by 59 mM-external K or 10(-5) M-carbachol. In the ear artery reserpine blocked the K-induced contraction but its effect on the contraction elicited by noradrenaline was smaller. At 0.2 mM-Ca, the inhibition of the tonic component of the noradrenaline-induced contraction was more pronounced than that of the phasic component. This reserpine action was fully reversible for the noradrenaline stimulus in the ear artery but less so for K-induced contractions. The inhibitory action on contractions induced in taenia coli by K-rich solution and by carbachol was even less reversible. The analysis of the effect of reserpine on the 45Ca exchange in the ear artery has revealed that it inhibits the increase of the fractional loss induced by K depolarization, but that it does not exert a significant effect on the increased fractional loss induced by 10(-5) M-noradrenaline. Reserpine slows down the filling with 45Ca of the agonist-sensitive store without affecting the steady-state amount of Ca taken up by the store. A study of the degree of filling of the store by measuring the force development and the 45Ca release elicited by noradrenaline in Ca-free medium, reveals that the force development after loading in a reserpine-containing medium remains less than the control, although the same amount of Ca is released from the store. It was shown by using tetrabenazine that the inhibitory action of reserpine on the Ca exchange and the force development is not due to an interaction of reserpine with the receptor molecules that are responsible for its depleting action on aminergic granules. These results strongly suggest that reserpine exerts a Ca antagonistic action on smooth muscle whereby it blocks the potential-dependent channels. However, reserpine also affects the receptor-operated channels to some extent and in addition at a high concentration it seems to exert an unspecific inhibitory action on the contractile system.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aprigliano O., Hermsmeyer K. In vitro denervation of the portal vein and caudal artery of the rat. J Pharmacol Exp Ther. 1976 Sep;198(3):568–577. [PubMed] [Google Scholar]
  2. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  3. Brimijoin S., Trendelenburg U. Reserpine-induced release of norepinephrine from isolated spontaneously beating guinea-pig atria. J Pharmacol Exp Ther. 1971 Jan;176(1):149–159. [PubMed] [Google Scholar]
  4. Casteels R., Droogmans G. Exchange characteristics of the noradrenaline-sensitive calcium store in vascular smooth muscle cells or rabbit ear artery. J Physiol. 1981 Aug;317:263–279. doi: 10.1113/jphysiol.1981.sp013824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DE LA LANDE I. S., PARKS V. J., SANDISON A. G., SKINNER S. L., WHELAN R. F. The peripheral dilator action of reserpine in man. Aust J Exp Biol Med Sci. 1960 Aug;38:313–320. doi: 10.1038/icb.1960.33. [DOI] [PubMed] [Google Scholar]
  6. Droogmans G., Raeymaekers L., Casteels R. Electro- and pharmacomechanical coupling in the smooth muscle cells of the rabbit ear artery. J Gen Physiol. 1977 Aug;70(2):129–148. doi: 10.1085/jgp.70.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giachetti A., Shore P. A. The reserpine receptor. Life Sci. 1978 Jul 10;23(2):89–92. doi: 10.1016/0024-3205(78)90254-0. [DOI] [PubMed] [Google Scholar]
  8. Login I. S., MacLeod R. M. The direct effect of reserpine in vitro on prolactin release from rat anterior pituitary glands. Brain Res. 1981 Jan 5;204(1):79–85. doi: 10.1016/0006-8993(81)90653-3. [DOI] [PubMed] [Google Scholar]
  9. Martinez J. R., Quissell D. O., Wood D. L., Giles M. Abnormal secretory response to parasympathomimetic and sympathomimetic stimulations from the submaxillary gland of rats treated with reserpine. J Pharmacol Exp Ther. 1975 Aug;194(2):384–395. [PubMed] [Google Scholar]
  10. NAYLER W. G. A direct effect of reserpine on ventricular contractility. J Pharmacol Exp Ther. 1963 Feb;139:222–229. [PubMed] [Google Scholar]
  11. PLUMMER A. J., EARL A., SCHNEIDER J. A., TRAPOLD J., BARRETT W. Pharmacology of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):8–21. doi: 10.1111/j.1749-6632.1954.tb45914.x. [DOI] [PubMed] [Google Scholar]
  12. Perlmutter J., Martinez J. R. The chronically reserpinized rat as a possible model for cystic fibrosis. VII. Alterations in the secretory response to cholecystokinin and to secretin from the pancreas in vivo. Pediatr Res. 1978 Mar;12(3):188–194. doi: 10.1203/00006450-197803000-00005. [DOI] [PubMed] [Google Scholar]
  13. QUINN G. P., SHORE P. A., BRODIE B. B. Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther. 1959 Oct;127:103–109. [PubMed] [Google Scholar]
  14. Shore P. A. Transport and storage of biogenic amines. Annu Rev Pharmacol. 1972;12:209–226. doi: 10.1146/annurev.pa.12.040172.001233. [DOI] [PubMed] [Google Scholar]
  15. Steinsland O. S., Furchgott R. F., Kirpekar S. M. Biphasic vasoconstriction of the rabbit ear artery. Circ Res. 1973 Jan;32(1):49–58. doi: 10.1161/01.res.32.1.49. [DOI] [PubMed] [Google Scholar]
  16. TRIPOD J., MEIER R. Wirkung von Serpasil (Reserpin, ein neues Alkaloid von Rauwolfia serpentina B.) auf isolierte Kreislauforgange. Arch Int Pharmacodyn Ther. 1954 Apr 1;97(3-4):251–266. [PubMed] [Google Scholar]
  17. Willerson J. T., Thompson R. H., Hookman P., Herdt J., Decker J. L. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. Ann Intern Med. 1970 Jan;72(1):17–27. doi: 10.7326/0003-4819-72-1-17. [DOI] [PubMed] [Google Scholar]
  18. Zonta F., D'Agostino G., Lucchelli A., Grana E. "Direct" effect of reserpine on various preparations. Farmaco Sci. 1976 Dec;31(12):856–864. [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES